within Pharmacolibrary.Drugs.ATC.G;

model G04BX15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.03,
    Cl             = 0.006833333333333333,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.048,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G04BX15</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Pentosan polysulfate sodium (PPS) is a semi-synthetic sulfated polysaccharide chemically related to heparin. It is primarily used in the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) and is approved for oral use in this indication in several countries. PPS may also have anticoagulant and anti-inflammatory properties. Its precise mechanism in IC is unclear but may involve glycosaminoglycan layer repair within the bladder.</p><h4>Pharmacokinetics</h4><p>Oral pharmacokinetic data reported in healthy adult volunteers. Data is limited and absorption is generally poor. Renal excretion is minimal.</p><h4>References</h4><ol><li><p>Narouze, S, et al., &amp; Rech, GR (2016). Perioperative Management of Patients Receiving Pentosan Polysulfate Sodium (Elmiron). <i>Regional anesthesia and pain medicine</i> 41(5) 658–None. DOI:<a href=&quot;https://doi.org/10.1097/AAP.0000000000000450&quot;>10.1097/AAP.0000000000000450</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27547908/&quot;>https://pubmed.ncbi.nlm.nih.gov/27547908</a></p></li><li><p>Faaij, RA, et al., &amp; Cohen, AF (1999). The oral bioavailability of pentosan polysulphate sodium in healthy volunteers. <i>European journal of clinical pharmacology</i> 54(12) 929–935. DOI:<a href=&quot;https://doi.org/10.1007/s002280050577&quot;>10.1007/s002280050577</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10192753/&quot;>https://pubmed.ncbi.nlm.nih.gov/10192753</a></p></li><li><p>Simon, M, et al., &amp; Modi, NB (2005). Metabolism of [3H]pentosan polysulfate sodium (PPS) in healthy human volunteers. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 35(8) 775–784. DOI:<a href=&quot;https://doi.org/10.1080/00498250500230586&quot;>10.1080/00498250500230586</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16278190/&quot;>https://pubmed.ncbi.nlm.nih.gov/16278190</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G04BX15;
